Monday, August 29, 2011

Part 5: The Ellis Martin Report with Ken Aldrich of International Stem Cell Corporation (ISCO.OB)

In this interview, Ellis Martin speaks with Kenneth Aldrich of International Stem Cell Corporation (ISCO.OB) about continuing research and revenue generated by Lifeline Stem Cell technology, including Lifeline Skin Care Creams. Is International Stem Cell working on a cure for melanoma or cancer? Not directly, but the company believes that their technology is being used by their client companies doing research for these cures. Listen to the interview for full details.

International Stem Cell Corp is paid sponsor of The Ellis Martin Report. Forward looking statements may have been made in this interview.

No comments:

Post a Comment